Aytu BioPharma, Inc. (AYTU) vs Rockwell Medical, Inc. (RMTI)
Aytu BioPharma, Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. is the larger, with a market value of $34.5M against $25.1M — 1.4× the size. Aytu BioPharma, Inc. grew revenue faster over the last twelve months: −13.3% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −24.8%) and the higher return on invested capital (−14.6% vs −20.0%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 11 and Aytu BioPharma, Inc. on 7.
Valuation
Profitability
| Metric | AYTU | RMTI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 63.95% | 17.71% | 53.94% |
| Operating margin | (14.44%) | (6.52%) | 0.00% |
| Net margin | (24.76%) | (7.33%) | 0.00% |
| Free cash flow margin | 5.62% | 2.47% | 0.00% |
| Return on equity | (52.55%) | (15.53%) | (0.40%) |
| Return on assets | (12.44%) | (9.32%) | (3.32%) |
| Return on invested capital | (19.99%) | (14.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack